The NIHR has selected BHP founder-member the University of Birmingham to run the National Collaborative for its Research Support Service (RSS) from 1 February 2024. The RSS was launched on 1 … Continue reading “University of Birmingham awarded £7m NIHR funding to provide strategic leadership for its Research Support Service”
News
LIBERATE heart attack trial treats first patient
The first patient has been treated in the LIBERATE clinical study to evaluate glenzocimab efficacy in myocardial infarction, which involves BHP members the University of Birmingham and University Hospitals Birmingham … Continue reading “LIBERATE heart attack trial treats first patient”
Aston University launches SPARK The Midlands to support health tech innovation
Aston University, a member of BHP, has launched SPARK The Midlands, a network which aims to bridge the gap between medical research discoveries of novel therapeutics, medical devices and diagnostics, … Continue reading “Aston University launches SPARK The Midlands to support health tech innovation”
New treatment combination may improve outcomes for children with rare cancers
Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumour drugs as well as chemotherapy, a new trial has found. … Continue reading “New treatment combination may improve outcomes for children with rare cancers”
Professor Amos Burke appointed Director of Birmingham’s Cancer Research UK Clinical Trials Unit (CRCTU)
Professor Amos Burke has been appointed as the new Director of the Cancer Research UK Clinical Trials Unit, based at BHP founder-member the University of Birmingham. Professor Burke – a … Continue reading “Professor Amos Burke appointed Director of Birmingham’s Cancer Research UK Clinical Trials Unit (CRCTU)”